MAOA and depressive symptom measurement: It is becoming clear that MAO-A overexpression is associated with prostate cellular dedifferentiation, tumorigenesis, aggressiveness, metastasis, as well as depressive symptoms, which dictate its inhibition, for potential PCa treatment and depression management.